Your browser doesn't support javascript.
loading
Ovarian malignant mixed Müllerian tumor: a rare case report from Tanzania.
Pallangyo, Angela; Pyuza, Jeremia J; Andongolile, Alice A; Mbwambo, Daniel; Claver, Jackson P; Koosa, Ummil-Khairat; Lema, Kennedy; Amsi, Patrick; Nkya, Gilbert; Mremi, Alex.
Afiliação
  • Pallangyo A; Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Pyuza JJ; Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Andongolile AA; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Mbwambo D; Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Claver JP; Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Koosa UK; Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Lema K; Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Amsi P; Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Nkya G; Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Mremi A; Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
J Surg Case Rep ; 2020(10): rjaa406, 2020 Oct.
Article em En | MEDLINE | ID: mdl-33123343
ABSTRACT
Malignant mixed Müllerian tumor of the ovary is rare aggressive tumor that is histologically defined by the presence of malignant epithelial and stromal components. We report a 37-year-old woman who consulted our facility complaining of abdominal distention and a painful palpable mass over her lower abdomen. Physical examination including computerized tomography revealed a complex cystic mass lesion on the left ovary with extensive omental involvement. Ovarian cancer was suspected and the patient underwent debulking surgery. The histopathology of the specimen revealed a high-grade tumor composed of both malignant epithelial and sarcomatous elements. Both epithelial and stromal components stained positive for p53 immunostaining. Before the initiation of chemotherapy, on 5th day postoperation, the patient was found unresponsive. The stage of the disease seems to be the most important prognostic factor, thus emphasis should be made to identify it in earlier stages.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article